ArticleEuropean heart journal. Cardiovascular pharmacotherapy2025

We have much more to learn about sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists.

Stefan AgewallPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.